MyFinsight
Home
Blog
About
Contact
krys: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$17,213K
Prepaid taxes
$10,103K
Inventory
$37,632K
Accounts receivable, net
$129,633K
Short-term investments
$338,465K
Cash and cash
equivalents
$392,604K
Other non-current
assets
$333K
Deferred tax asset, net of
valuation allowance
$24,680K
Right-of-use assets
$7,447K
Long-term investments
$133,113K
Property and equipment,
net
$148,871K
Total current assets
$925,650K
Total assets
$1,240,094K
Total liabilities and
stockholders equity
$1,240,094K
Total stockholders
equity
$1,137,876K
Total liabilities
$102,218K
Accumulated deficit
-$27,237K
Accumulated other
comprehensive gain (loss)
$1,100K
Additional paid-in capital
$1,164,013K
Other long-term
liabilities
$3,137K
Lease liability
$7,813K
Total current
liabilities
$91,268K
Accrued expenses and
other current...
$31,704K
Accrued rebates
$55,769K
Current portion of lease
liability
$1,698K
Accounts payable
$2,097K
Back
Back
Balance Sheet
source: myfinsight.com
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)